10X Genomics

Youtube Subscribe

Open: 60.41 Close: 60.74 Change: 0.33

We programmed an AI to read Internet. This is what it found out about 10X Genomics Company Inc.

This document will help you to evaluate 10X Genomics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about 10X Genomics are: Genomics, company, result, stock, CEO, share, Bryan, …

Concept Map

Semantic Network

Stock Summary

Bryan Roberts informed the company of his decision to resign from the company. CEO Serge Saxonov sold 2,000 shares of the firms stock in a transaction that occurred on Monday, May 15th. CEO has a 52-week low.

Today's Summary

Bryan Roberts informed the company of his decision to resign from the company. CEO Serge Saxonov sold 2,000 shares of the firms stock in a transaction that occurred on Monday, May 15th. CEO has a 52-week low of $23.81.

Today's News

Bryan Roberts resigns from the board of directors, effective immediately. Bryan Roberts informed the company of his decision to resign from the company. 10x Genomics to report financial results for the second quarter 2023. Analyst Consensus: Buy Stock Forecasts. Analyst consensus: Buy stock price, buy stock. 10x Genomics will report financial results for the fourth quarter and full year ended December 31, 2022 after market. CEO Serge Saxonov joins Yahoo Finance live anchor Rachell Akuffo to discuss biotechnology innovation. Stephens initiated coverage on shares of 10x Genomics with an “overweight” rating and a target price of $65.00 for the company. As of Tuesdays trading session, shares opened at $59.86 with a market cap. The Iowa NeuroBank Core has been offering 10x Genomics Visium Spatial Transcriptomics Service since 2021, and being part of the Visium Enabled Program (VEP) for additional 10X Genomics consumable discounts. 10x Genomics is seeking a Tender and Proposal Manager - Life Sciences. Pathology Assistant Income Estimation: $62,744 - $110,525 Cytotechnologist Income Estimated: $78,016 - $93,899 10X Genomics has filed 474 patents. Goldman Sachs Maintains 10x Genomics Inc – (TXG) Sell Recommendation Jul 13, 2023 Mixed model-based deconvolution of cell-state abundances (MeDuSA) along a one-dimensional trajectory. 10x Genomics ( NASDAQ:TXG – Get Free Report ) last released its quarterly earnings results on Wednesday, May 3rd. CEO Serge Saxonov sold 2,000 shares of the firms stock in a transaction that occurred on Monday, May 15th. CEO has a 52-week low of $23.81.

Stock Profile

" Bryan Roberts resigns from the board of directors, effective immediately. Bryan Roberts informed the company of his decision to resign from the company. 10x Genomics to report financial results for the second quarter 2023. Analyst Consensus: Buy Stock Forecasts. Analyst consensus: Buy stock price, buy stock. 10x Genomics will report financial results for the fourth quarter and full year ended December 31, 2022 after market. CEO Serge Saxonov joins Yahoo Finance live anchor Rachell Akuffo to discuss biotechnology innovation. Stephens initiated coverage on shares of 10x Genomics with an “overweight” rating and a target price of $65.00 for the company. As of Tuesdays trading session, shares opened at $59.86 with a market cap. The Iowa NeuroBank Core has been offering 10x Genomics Visium Spatial Transcriptomics Service since 2021, and being part of the Visium Enabled Program (VEP) for additional 10X Genomics consumable discounts. 10x Genomics is seeking a Tender and Proposal Manager - Life Sciences. Pathology Assistant Income Estimation: $62,744 - $110,525 Cytotechnologist Income Estimated: $78,016 - $93,899 10X Genomics has filed 474 patents. Goldman Sachs Maintains 10x Genomics Inc – (TXG) Sell Recommendation Jul 13, 2023 Mixed model-based deconvolution of cell-state abundances (MeDuSA) along a one-dimensional trajectory. 10x Genomics ( NASDAQ:TXG – Get Free Report ) last released its quarterly earnings results on Wednesday, May 3rd. CEO Serge Saxonov sold 2,000 shares of the firms stock in a transaction that occurred on Monday, May 15th. CEO has a 52-week low of $23.81."

Keywords

Are looking for the most relevant information about 10X Genomics? Investor spend a lot of time searching for information to make investment decisions in 10X Genomics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about 10X Genomics are: Genomics, company, result, stock, CEO, share, Bryan, and the most common words in the summary are: genomics, market, exhibit, data, stock, job, inc, . One of the sentences in the summary was: CEO Serge Saxonov sold 2,000 shares of the firms stock in a transaction that occurred on Monday, May 15th. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #genomics #market #exhibit #data #stock #job #inc.

Read more →

Youtube Subscribe

---